Relationship between Serum Dehydroepiandrosterone Levels and Heart Ejection Fraction in Heart Failure Patients

Authors

  • Rima Hayyu Chrisnanda Department of Clinical Pathology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya
  • M. Robiul Fuadi Department of Clinical Pathology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya
  • S.P. Edijanto Department of Clinical Pathology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya
  • M. Yusuf Department of Cardiology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

DOI:

https://doi.org/10.24293/ijcpml.v27i2.1664

Keywords:

Dehydroepiandrosterone, DHEAS, ejection fraction, heart failure

Abstract

Cardiovascular disease is still a serious problem in the world of health. Life expectancy after being diagnosed with heart failure is 50% and 10% for 5 and 10 years. Steroid hormones such as Dehydroepiandrosterone (DHEAS) have cardioprotective effects by inhibiting the formation of atherosclerotic plaque, pulmonary artery vasodilators, and protecting cardiomyocytes. DHEAS levels decrease with age. Decreased DHEAS levels are associated with an increased risk of cardiovascular disease. This study aimed to know the relationship between DHEAS levels in serum and ejection fractions in heart failure patients. This cross-sectional study used a sample of 34 people aged > 30 years who had been diagnosed with heart failure by a specialist in the Department of Cardiology and Vascular Medicine. The diagnosis of heart failure uses Echocardiography to determine the ejection heart fraction. DHEAS levels were taken from venous blood and examined using the CLEIA method with an IMMULITE device (Siemens Healthineers, Germany). Statistical analysis was performed by Spearman correlation test, with a significance level of p < 0.05. Thirty-four research subjects found that 13 patients had an ejection fraction of 40% (Heart Failure with Reduced Ejection Fraction/HFrEF), 12 patients had an ejection fraction of 41-49% (borderline) and 9 patients had an ejection fraction of ≥ 50% (Heart Failure with Preserved Ejection Fraction/HFpEF). Spearman correlation test results obtained a correlation coefficient or r=0.357 with a value of p=0.038, which meant there was a significant relationship between DHEAS with ejection fraction (p < 0.05). The lower the DHEAS level, the ejection
fraction would also be lower. Further with age, DHEAS levels get lower. The lower the DHEAS level, the lower the ejection fraction.

Downloads

Download data is not yet available.

Author Biographies

Rima Hayyu Chrisnanda, Department of Clinical Pathology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

Department of Clinical Pathology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

M. Robiul Fuadi, Department of Clinical Pathology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

Department of Clinical Pathology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

S.P. Edijanto, Department of Clinical Pathology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

Department of Clinical Pathology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

M. Yusuf, Department of Cardiology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

Department of Cardiology, Faculty of Medicine, Airlangga University/Dr. Soetomo Hospital, Surabaya

References

Mannella P, Simoncini T, Caretto M, Genazzani AR. Dehydroepiandrosterone and cardiovascular disease. Italy, Elsevier Inc, 2018; 108.

Kementerian Kesehatan Republik Indonesia. Riset kesehatan dasar. 2013; 88–94.

N Sen, S Tanwar, A Jain, J Sharma, RK Gorkhroo, A Mehta, B Kalra. Assessment of testosterone/estradiol ratio, DHEA-S level and correlation with coronary inflammatory markers IL-1 & 6, TNF-1 and hsCRP predict 5 years risk of cardiovascular disease in men. European Heart Journal, 2019; 40: 746-781.

Jia X, Sun W, Hoogeven R, Nambi V, Virani S, et al. Association of plasma Dehydroepiandrosterone

sulphate (DHEAS) with incident heart failure in older men and women. Journal of the America College of

Cardiology, 2020; 75: 126-132.

Münzel T, Camici GG, Maack C, Bonetti NR, Fuster V, Kovacic JC. Impact of oxidative stress on the heart and vasculature: Part 2 of a 3-part series. J. Am. Coll. Cardiol, 2017; 70: 212–229.

Jimerez MC, Tucker KL, Rodriguez F, Porneala B, Meigs JB, Lopez L. Cardiovascular risk factor and

Dehydroepiandrosterone sulphate among Latinos in the Boston Puerto Rico Health Study. Journal of the

Endocrine Society, 2019; 3: 291-303.

Macini A, Fuvuzzi AM, Bruno C, Nicolazzi MA, Vergani E, et al. Anabolic hormone deficiencies in heart failure with reduced or preserved ejection fraction and correlation with plasma total antioxidant capacity. International Journal of Endocrinology, 2020; 20: 1-8.

Vigue MJ, Rossier MF. In-vivo and in-vitro evidences of Dehydroepidrosterone on the cardiovascular system. Int J Endocrinol Metab, 2015; 13(2): e24660.

Bu B Yeap, Girish Dwivedi. Androgens and heart failure: New observation illuminating in ageing

condrum. The Journal of Clinical Endocrinology and Metabolism, 2020; 02597.

Aoki K, Terauchi Y. Effect of DHEAS on diabetes mellitus and obesity. Japan, Elsevier Inc, 2018; 108.

Leff-Gelman P, Flores-Ramos M, Carraso AEA, Lopez M, Takashima MF, et al. Cortisol and DHEAS level in pregnant women with severe anxiety. BMC Psychiatry, 2020; 393.

Kumi H, Ohira T, Nagayoshi M, Kajiura M, Imano H, et al. Dehydroepiandrosterone-sulphate is associated with cardiovascular reactivity to stress in women. Journal of Psychoneuroendocrinology, 2016; 69: 116–22.

Ting WT, Chen Y, Zhou Y, Adi D, Zheng YY, et al. Prognostic value of Dehydroepiandrosterone sulphate for patients with cardiovascular disease: A systematic review and meta-analysis. Journal of the American Heart Association, 2017; 6(5): 1–13.

Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI). Pedoman tatalaksana gagal

jantung. Buku pedoman tatalaksana gagal jantung. Ed pertama., Jakarta, PERKI, 2015; 14–27.

Downloads

Submitted

2020-06-30

Accepted

2021-01-26

Published

2021-04-15

How to Cite

[1]
Chrisnanda, R.H., Fuadi, M.R., Edijanto, S. and Yusuf, M. 2021. Relationship between Serum Dehydroepiandrosterone Levels and Heart Ejection Fraction in Heart Failure Patients. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 27, 2 (Apr. 2021), 201–204. DOI:https://doi.org/10.24293/ijcpml.v27i2.1664.

Issue

Section

Articles